Margaret G. McGlynn, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 10,000 shares at $262.97 ($2.6M) on 2022-03-31, disclosed to the SEC on 2022-04-04.
Open-market sale of $2.6M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $261.28 | 1,019 | $266K | 10.2% |
| 2 | $261.28 | 1,019 | $266K | 10.2% |
| 3 | $262.37 | 2,970 | $779K | 29.7% |
| 4 | $262.37 | 2,970 | $779K | 29.7% |
| 5 | $262.97 | 1,011 | $266K | 10.1% |
| 6 | $262.97 | 1,011 |
| $266K |
| 10.1% |
| Total | $262.27 avg | 10,000 | $2.6M | 100% |
| Filing → |
| FOLD | SELL | 2022-05-04 | $105K | — | Filing → |
| VRTX | SELL | 2022-04-12 | $1.4M | — | Filing → |
| VRTX | SELL | 2022-02-01 | $2.2M | — | Filing → |